Risk factors for progression of interstitial lung disease in Sjögren's syndrome: a single-centered, retrospective study
- PMID: 34757493
- DOI: 10.1007/s10067-021-05984-1
Risk factors for progression of interstitial lung disease in Sjögren's syndrome: a single-centered, retrospective study
Abstract
Objective: To identify clinical characteristics and risk factors related to the progression of interstitial lung disease (ILD) in patients with primary Sjögren's syndrome (pSS).
Methods: In this single-centered, retrospective study, a total of 83 identified pSS-ILD patients with relatively complete clinical data were finally enrolled. Clinical symptoms, laboratory data, high-resolution computed tomography (HRCT), and pulmonary function test (PFT) results were collected. A logistic regression analysis was performed to determine the independent risk factors for ILD progression, and a nomogram was plotted to construct a predictive model.
Results: The prevalence of pSS-ILD in our study was 18.89%. Among the 83 enrolled patients, 32 (38.6%) underwent ILD progression. The characteristic features associated with the progression of ILD included male sex, non-sicca onset, reticular pattern on HRCT, higher levels of baseline lactic dehydrogenase (LDH), and low baseline forced vital capacity (FVC). The results of multivariate logistic regression indicated that LDH (OR 1.008, p = 0.030) was an independent risk factor for ILD progression, while sicca onset (OR 0.254, p = 0.044) and FVC (OR 0.952, p = 0.003) were protective factors for ILD progression. A simple predictive model for ILD progression in pSS was developed and validated.
Conclusion: pSS patients with non-sicca onset, high baseline LDH level, and low baseline FVC were at higher risk of ILD progression.
Keywords: Clinical characteristics; Interstitial lung disease; Prognosis; Risk factors; Sjögren’s syndrome.
© 2021. International League of Associations for Rheumatology (ILAR).
References
-
- Mariette X, Criswell LA (2018) Primary Sjogren’s syndrome. N Engl J Med 378:931–939. https://doi.org/10.1056/NEJMcp1702514 - DOI - PubMed
-
- Flament T, Bigot A, Chaigne B, Henique H, Diot E, Marchand-Adam S (2016) Pulmonary manifestations of Sjogren’s syndrome. Eur Respir Rev 25:110–123. https://doi.org/10.1183/16000617.0011-2016 - DOI - PubMed
-
- Peredo RA, Beegle S (2021) Sjogren’s syndrome and pulmonary disease. Adv Exp Med Biol 1303:193–207. https://doi.org/10.1007/978-3-030-63046-1_12 - DOI - PubMed
-
- Reina D, Roig Vilaseca D, Torrente-Segarra V et al (2016) Sjogren’s syndrome-associated interstitial lung disease: a multicenter study. Reumatol Clin 12:201–205. https://doi.org/10.1016/j.reuma.2015.09.003 - DOI - PubMed
-
- Zhao R, Wang Y, Zhou W et al (2020) Associated factors with interstitial lung disease and health-related quality of life in Chinese patients with primary Sjogren’s syndrome. Clin Rheumatol 39:483–489. https://doi.org/10.1007/s10067-019-04753-5 - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical